Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
HUTCHMED (China) Limited (GB:HCM)
LSE:HCM
RESEARCH TOOLSreports
HUTCHMED (China) Limited (HCM) Share Forecast & Price Target
2 Followers
See the Price Targets and Ratings of:
HCM Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HCM Stock 12 Month Forecast
Average Price Target
360.26p
▲(31.96% Upside)
| Highest Price Target360.26p | Average Price Target360.26p | Lowest Price Target360.26p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
CMB International Securities
346.24p
Buy
26.83%
Upside
Reiterated
03/01/24
We anticipate the US NDA submission for accelerated approval by the end of 2024, and savolitinib potentially to be positioned as HCM's second product to reach the global market. Compared with other competing therapies, savolitinib + osimertinib offers potentially better efficacy for specific MET+ patients, and its oral administration route is more convenient over other competing therapies. In China, savolitinib has the potential to expand its label into 1L MET Exon 14 NSCLC with the filing expected in 1Q24E based on positive results from confirmatory Ph3b study.
Goldman Sachs
1,182.66p→1,340.35p
Hold
390.97%
Upside
Reiterated
11/10/23
Hutchison China MediTech Ltd. (HCM) PT Raised to $17 at Goldman SachsGoldman Sachs analyst Paul Choi raised the price target on Hutchison China MediTech Ltd. (NASDAQ: HCM) to $17.00 (from $15.00) while maintaining a Neutral rating.
Citi
322.92p→403.66p
Buy
47.86%
Upside
Reiterated
11/10/23
Hutchmed China Ltd (13:HK) PT Raised to HK$40 at CitiCiti analyst John Yung raised the price target on Hutchmed China Ltd (13:HK) to HK$40.00 (from HK$32.00) while maintaining a Buy rating.
CLSA
380p→390p
Buy
42.86%
Upside
Reiterated
08/03/23
HUTCHMED China Ltd (HCM:LN) PT Raised to GBP3.90 at CLSACLSA analyst Matthew Yan raised the price target on HUTCHMED China Ltd (HCM:LN) to GBP3.90 (from GBP3.80) while maintaining a Buy (1) rating.
Best Analysts Covering HUTCHMED (China) Limited
Which Analyst Should I Follow If I Want to Buy GB:HCM and Sell After:
1 Month
3 Months
1 Year
Success Rate
2/3 ratings generated profit
Average Return
+9.43%
reiterated a buy rating 4 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +9.43% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HCM Analyst Recommendation Trends
Rating
Jun 23
Aug 23
Nov 23
Mar 24
Apr 24
Strong Buy
0
0
0
0
0
Buy
2
4
6
6
4
Hold
1
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
5
7
7
5
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
HCM Financial Forecast
HCM Stock Forecast FAQ
What is GB:HCM’s average 12-month price target, according to analysts?
Based on analyst ratings, HUTCHMED (China) Limited’s 12-month average price target is 360.26p.
What is GB:HCM’s upside potential, based on the analysts’ average price target?
HUTCHMED (China) Limited has 31.96% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HUTCHMED (China) Limited a Buy, Sell or Hold?
HUTCHMED (China) Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is HUTCHMED (China) Limited’s share price target?
The average share price target for HUTCHMED (China) Limited is 360.26p. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 360.26p ,and the lowest forecast is 360.26p. The average share price target represents 31.96% Increase from the current price of 273p.
The highest analyst share price target is 360.26p ,and the lowest forecast is 360.26p. The average share price target represents 31.96% Increase from the current price of 273p.
What do analysts say about HUTCHMED (China) Limited?
HUTCHMED (China) Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of HUTCHMED (China) Limited?
To buy shares of GB:HCM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.